DK585889D0 - PHARMACEUTICAL PREPARATION - Google Patents

PHARMACEUTICAL PREPARATION

Info

Publication number
DK585889D0
DK585889D0 DK585889A DK585889A DK585889D0 DK 585889 D0 DK585889 D0 DK 585889D0 DK 585889 A DK585889 A DK 585889A DK 585889 A DK585889 A DK 585889A DK 585889 D0 DK585889 D0 DK 585889D0
Authority
DK
Denmark
Prior art keywords
polyoxyethylene glycol
component
carboxylic acid
pharmaceutical preparation
ester
Prior art date
Application number
DK585889A
Other languages
Danish (da)
Other versions
DK585889A (en
Inventor
Maria Oksana Bachynsky
Martin Howard Infeld
Navnit Shah
Joel Unowsky
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK585889D0 publication Critical patent/DK585889D0/en
Publication of DK585889A publication Critical patent/DK585889A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/25—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Pharmaceutical product containing (a) a compound with antibacterial activity, and (b) an effective amount of an absorption-promoting 2-component system which contains as first component (b 1) an ether composed of a C6-C18-alcohol and polyoxyethylene glycol and as second component either (b 2-1) a polyoxyethylene glycol C6-C18-carboxylic acid glyceride ester, or (b 2-2) a C6-C18-carboxylic acid or a pharmaceutically utilisable salt thereof, or (b 2-3) an ester composed of two or more C6-C18-carboxylic acids, glycerol and a polyoxyethylene glycol.
DK585889A 1988-11-22 1989-11-21 PHARMACEUTICAL PREPARATION DK585889A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27459088A 1988-11-22 1988-11-22

Publications (2)

Publication Number Publication Date
DK585889D0 true DK585889D0 (en) 1989-11-21
DK585889A DK585889A (en) 1990-05-23

Family

ID=23048828

Family Applications (1)

Application Number Title Priority Date Filing Date
DK585889A DK585889A (en) 1988-11-22 1989-11-21 PHARMACEUTICAL PREPARATION

Country Status (15)

Country Link
EP (1) EP0370481B1 (en)
JP (1) JPH0774165B2 (en)
KR (1) KR900007412A (en)
AT (1) ATE94765T1 (en)
AU (1) AU625276B2 (en)
CA (1) CA2003340A1 (en)
DE (1) DE58905681D1 (en)
DK (1) DK585889A (en)
HU (1) HU205713B (en)
IE (1) IE63119B1 (en)
IL (1) IL92357A (en)
NZ (1) NZ231447A (en)
PH (1) PH26390A (en)
YU (1) YU221889A (en)
ZA (1) ZA898331B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4115849A1 (en) * 1991-05-15 1992-11-19 Lohmann Therapie Syst Lts PENETRATION PROMOTING SUBSTANCE
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
SI9400338A (en) * 1994-08-31 1996-04-30 Lek D D Vancomycin hydrochloride suspensions for peroral use and for filling into soft ,gelatine capsules.
IT1275802B1 (en) * 1994-11-03 1997-10-17 Hoffmann La Roche INTERFERONE COMPOSITION
FR2775188B1 (en) * 1998-02-23 2001-03-09 Lipha IMMEDIATE RELEASE ORAL EXTENDED RELEASE GALENIC FORM COMPRISING AN ABSORPTION PROMOTING AGENT AND USE OF THE ABSORPTION PROMOTING AGENT
IL125244A (en) * 1998-07-07 2002-12-01 Yissum Res Dev Co Pharmaceutical compositions containing low-melting waxes
EP1154761B1 (en) * 1999-02-22 2008-02-20 Merrion Research I Limited Solid oral dosage form containing an enhancer
US8119159B2 (en) 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
JP4489356B2 (en) 2001-05-11 2010-06-23 メリオン リサーチ スリー リミテッド Penetration enhancer
MX2008012678A (en) 2006-04-07 2008-12-17 Merrion Res Iii Ltd Solid oral dosage form containing an enhancer.
KR20110007242A (en) 2008-05-07 2011-01-21 메리온 리서치 Ⅲ 리미티드 Compositions of peptides and processes of preparation thereof
NZ591810A (en) 2008-09-17 2012-12-21 Chiasma Inc Pharmaceutical compositions and related methods of delivery the composition comprises a medium chain fatty acid
US9089484B2 (en) 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
CN103476419A (en) 2011-01-07 2013-12-25 梅里翁第三研究有限公司 Pharmaceutical compositions of iron for oral administration
ES2975708T3 (en) 2015-01-29 2024-07-12 Novo Nordisk As Tablets comprising GLP-1 agonist and enteric coating
US10238709B2 (en) 2015-02-03 2019-03-26 Chiasma, Inc. Method of treating diseases
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1168949A (en) * 1979-08-13 1984-06-12 William G. Gorman Cleansing compositions
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
JPS59212427A (en) * 1983-05-19 1984-12-01 Kyoto Yakuhin Kogyo Kk Composition for rectum administration
EP0126348A2 (en) * 1983-05-19 1984-11-28 Kyoto Pharmaceutical Industries, Ltd. Composition for rectal administration and method of promoting rectal drug absorption
CA1256799A (en) * 1984-02-22 1989-07-04 Walter Fuller Suppositories
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs

Also Published As

Publication number Publication date
YU221889A (en) 1992-05-28
EP0370481A2 (en) 1990-05-30
NZ231447A (en) 1992-09-25
IL92357A (en) 1994-10-07
IE63119B1 (en) 1995-03-22
EP0370481B1 (en) 1993-09-22
IE893718L (en) 1990-05-22
DE58905681D1 (en) 1993-10-28
HU205713B (en) 1992-06-29
DK585889A (en) 1990-05-23
JPH0774165B2 (en) 1995-08-09
HU896123D0 (en) 1990-02-28
EP0370481A3 (en) 1991-01-16
ZA898331B (en) 1990-07-25
KR900007412A (en) 1990-06-01
HUT52374A (en) 1990-07-28
PH26390A (en) 1992-07-02
AU4538489A (en) 1990-05-31
AU625276B2 (en) 1992-07-09
ATE94765T1 (en) 1993-10-15
IL92357A0 (en) 1990-07-26
CA2003340A1 (en) 1990-05-22
JPH02180837A (en) 1990-07-13

Similar Documents

Publication Publication Date Title
DK585889A (en) PHARMACEUTICAL PREPARATION
DE3669882D1 (en) 2-CYANACRYLIC ACID ESTER COMPOSITION.
NO863061L (en) PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE PHENOXYDICOIC ACID DERIVATIVES.
DK581185D0 (en) PHARMACEUTICAL PREPARATION CONTAINING 13-CIS-A-VITAMIC ACID
DE3868037D1 (en) PHARMACEUTICAL COMPOSITION WITH DELAYED DELIVERY OF ACTIVE SUBSTANCE.
NO862734L (en) PROCEDURE FOR THE PREPARATION OF HYALURONIC ACID ESTERS.
DE3884517D1 (en) BIOLOGICALLY ACTIVE CARBON ACID ESTERS.
MY100647A (en) Pharmaceuticals formulations.
DE3778132D1 (en) 2-BETA-SUBSTITUTED METHYLPENICILLANIC ACID DERIVATIVES AND THEIR SALTS AND ESTERS.
KR920701213A (en) Methylenediphosphonic acid compound and anti-inflammatory agent using it as an active ingredient
DE3674351D1 (en) Optically active benzoic acid ester derivatives.
IL65922A0 (en) Preparation of apovincaminic acid esters,certain novel optically active derivatives thereof and pharmaceutical compositions containing them
IT8267345A0 (en) COMPOUND AND PHARMACEUTICAL COMPOSITION TO ACCELERATE WOUND HEALING
PH21875A (en) Novel carboxylic acid esters,their method of use and insecticides containing them as the active ingredient
DK99085D0 (en) PHARMACEUTICAL PREPARATIONS CONTAINING A-VITAMIC ACID DERIVATIVES
IT8619288A0 (en) INJECTABLE PHARMACEUTICAL FORMULATIONS OF ACTIVE INGREDIENTS GENERAL ANESTHETICAL SUITABILITY.
NO863005D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,4,5,6,7,8-HEXSAHYDRO-2-ALKYL-4-ARYL-5-OXO-1,7-NAFTYRIDINE-3-CARBOXYL ACID ESTER DERIVATIVES.
NL8100209A (en) METHYLPENAMCARBONIC ACID SULPHONES, SALTS AND THEIR ESTERS, AND MEDICINAL PREPARATIONS CONTAINING THESE COMPOUNDS AS AN ACTIVE COMPONENT.
IT8447848A0 (en) 7-(1-PYRRYL)- AND 7-(1-PYRROLIDINIL)-6-FLUORO-1-ETHYL-1,4-DIHYDRO4-KETOQUINOLIN-3-CARBOXYLIC ACIDS ANTIMICROBIAL ADAPTIVITIES, THEIR PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOUNDS THAT THEM THEY CONTAIN
JPS56128731A (en) Ester of arylpropionic acid, manufacture and medicine of effective ingredient
ATE95164T1 (en) BIOLOGICALLY ACTIVE CARBONIC ACID ESTERS.
NO851195L (en) PROCEDURE FOR THE PREPARATION OF ASCORBIC ACID ESTERS.
IL59304A0 (en) Pharmaceutical preparation comprising as active ingredient acetyl salicylic acid or salicylic acid
ATE71079T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ALPHA-HALOGENATED DICARBONIC ACIDS.
PT87077A (en) TERC-BUTYLAMINO-3- (PHENYL-2: -PHENOXY) -1-PROPANOL-2 AND ITS ACID ADDITION SALTS FOR USE AS AN ACTIVE THERAPEUTIC SUBSTANCE

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment